Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...

The "Cochlear Ltd (COH) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable ...

Morgan Stanley analyst Sean Laaman downgraded Cochlear Limited (CHEOF – Research Report) to a Sell today and set a price target of A$240.00. The company’s shares closed last Wednesday at $176.30.

Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...

LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...

Investors continue to question valuation and wait for stronger earnings momentum. The post Cochlear shares lag the ASX 200 after a tough year. Is it time to buy? appeared first on The Motley Fool ...

Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.

Using visual support technology powered by TechSee, Cochlear has been able to bolster their customer experience by focusing on the needs of recipients through the use of Augmented Reality. NEW YORK, ...

LONE TREE, Colo., May 3, 2021 /PRNewswire/ -- Adults with cochlear implants may be able to improve their listening and communications skills in daily life with the help of a new self-guided digital ...

Cochlear Limited (AU:COH) has released an update. Cochlear Limited recently reported changes in the interests of its director, Diggory William Howitt, involving the acquisition of 11,000 shares and ...

Cochlear Limited (AU:COH) has released an update. Cochlear Limited has announced a continuation of its share buy-back program, purchasing 2,500 shares on the previous day, adding to the 44,500 already ...

MONTPELLIER, France & SYDNEY--(BUSINESS WIRE)--Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology, which specializes in the development of novel ...